SKI Market

A+| A| A-|

Indian Indices

Sensex

74,532.96 325.72
( 0.44%)

Global Indices

Nasdaq

46,043.89 -202.27
(-0.44%)

Dow Jones

6,628.50 -17.20
(-0.26%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

92.72 0.33
(0.36%)

EUR-INR

106.76 0.38
(0.35%)

GBP-INR

123.58 0.43
(0.35%)

JPY-INR

0.58 0.00
(0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

95.9

418528

EPS(TTM)

Face Value()

Div & Yield %

18.19

0.92

Back

Relonchem receives UK MHRA's approval for Cetirizine Dihydrochloride 1 mg/ml Oral Solution

Nov 20,2025

Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for its product Cetirizine Dihydrochloride 1 mg/ml Oral Solution from UK MHRA.

74,532.96 325.72 ( 0.44%)

46,043.89 -202.27 (-0.44%)

6,628.50 -17.20 (-0.26%)

53,297.18 -1,942.22 (-3.52%)

9,927.54 -135.96 (-1.35%)

92.72 0.33 (0.36%)

106.76 0.38 (0.35%)

123.58 0.43 (0.35%)

0.58 0.00 (0.28%)